Detalhe da pesquisa
1.
HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier.
Proc Natl Acad Sci U S A
; 120(8): e2215792120, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795752
2.
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors.
Nat Chem Biol
; 18(11): 1270-1276, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36076082
3.
The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.
Proc Natl Acad Sci U S A
; 118(3)2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431684
4.
A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity.
J Virol
; 95(15): e0235020, 2021 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980592
5.
Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library.
Protein Sci
; 30(4): 716-727, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586288
6.
Crystal structure of AdoMet radical enzyme 7-carboxy-7-deazaguanine synthase from Escherichia coli suggests how modifications near [4Fe-4S] cluster engender flavodoxin specificity.
Protein Sci
; 28(1): 202-215, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30341796